Release test results
99.697%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.03 mg
Related impurities (total)0.303%
Endotoxin<1.0 EU/mg
HPLC retention time5.92 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundGLP-1-SM
Presentation10 MG
Lot numberRGX-26-GLP-793
COA numberNS-2026-05089
Test date24 Apr 2026
Release date27 Apr 2026
Independent labNordicstar Labs
StatusSuperseded
GLP-1-SM — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-GLP-1007 | 10 MG | Aug 4, 2026 | 99.763% | Current |
| RGX-26-GLP-1008 | 15 MG | Aug 4, 2026 | 99.580% | Current |
| RGX-26-GLP-1009 | 20 MG | Aug 3, 2026 | 99.723% | Current |
| RGX-26-GLP-1010 | 30 MG | Aug 3, 2026 | 99.685% | Current |
| RGX-26-GLP-790 | 30 MG | Apr 26, 2026 | 99.705% | Superseded |
| RGX-26-GLP-793 this lot | 10 MG | Apr 24, 2026 | 99.697% | Superseded |
| RGX-26-GLP-792 | 15 MG | Apr 23, 2026 | 99.636% | Superseded |
| RGX-26-GLP-791 | 20 MG | Apr 20, 2026 | 99.712% | Superseded |
| RGX-26-GLP-691 | 20 MG | Jan 25, 2026 | 99.743% | Superseded |
| RGX-26-GLP-690 | 30 MG | Jan 23, 2026 | 99.598% | Superseded |
| RGX-26-GLP-693 | 10 MG | Jan 22, 2026 | 99.674% | Superseded |
| RGX-26-GLP-692 | 15 MG | Jan 20, 2026 | 99.750% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →